<DOC>
	<DOCNO>NCT00604435</DOCNO>
	<brief_summary>This study design determine efficacy safety neoadjuvant docetaxel epirubicin ( DE ) without human recombinant endostatin ( endostar ) breast cancer patient . The hypothesis protocol combine angiogenesis inhibit therapy chemotherapy could enhance cytotoxic activity breast cancer .</brief_summary>
	<brief_title>Neoadjuvant Endostatin Chemotherapy Breast Cancer</brief_title>
	<detailed_description>This open label , prospective , randomize , phase II clinical trial . A total 60 patient core-biopsy confirm breast cancer , stage ⅡA ⅢC , treat neoadjuvant systemic therapy eligible entry study . Patients allocate randomly two group receive either 3 cycle neoadjuvant DE endostar 3 cycle neoadjuvant DE . All case receive mammography , contrast-enhanced ultrasound ( CEUS ) , magnetic resonance angiography ( MRA ) , positron emission tomography ( PET ) scan pre- post-neoadjuvant therapy , undergo surgical resection . The primary endpoint clinical/pathological response . The secondary endpoint ( 1 ) safety tolerability regimen , ( 2 ) role mammography , CEUS , MRA PET response evaluation , ( 3 ) angiogenic profile biological information involve tumor response .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<mesh_term>Endostatins</mesh_term>
	<criteria>Histologically confirm invasive breast cancer ( core needle biopsy breast cancer diagnosis fine needle aspiration lymph node metastasis diagnosis ) Stage ⅡAⅢC Age 1870 ECOG performance status 02 No evidence distant metastasis No previous therapy Normal hematologic function leave ventricular ejection fraction great 50 percent No abnormality renal liver function Written inform consent With allergic constitution possible allergic reflection drug use study Any concurrent uncontrolled medical psychiatric disorder History severe heart disease , include congestive heart failure , unstable angina , uncontrolled arrhythmia , myocardial infarction , uncontrolled high blood pressure , heart valve disease . History bleed diathesis Being pregnant nursing</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>neoadjuvant chemotherapy</keyword>
	<keyword>docetaxel</keyword>
	<keyword>epirubicin</keyword>
	<keyword>recombinant human endostatin ( endostar )</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>endostatin</keyword>
</DOC>